Bioavailability of diphenylhydantoin.

Suppr

超能文献

作者信息

Albert K S, Sakmar E, Hallmark M R, Weidler D J, Wagner J G

出版信息

Clin Pharmacol Ther. 1974 Oct;16(4):727-35. doi: 10.1002/cpt1974164727.

DOI:10.1002/cpt1974164727

PMID:4609344

Abstract

摘要

相似文献

Bioavailability of diphenylhydantoin.

Clin Pharmacol Ther. 1974 Oct;16(4):727-35. doi: 10.1002/cpt1974164727.

Plasma level studies on different brands of sodium diphenylhydantoin (DPH) and primidone.

Int J Clin Pharmacol Biopharm. 1975 Oct;12(3):309-14.

Bioavailability and dissolution of proprietary and generic formulations of phenytoin.

J Neurol Neurosurg Psychiatry. 1992 Aug;55(8):688-91. doi: 10.1136/jnnp.55.8.688.

[Comparative study of phenytoin availability from pharmaceutical preparations].

Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Neurol Psihiatr Neurochir. 1986 Oct-Dec;31(4):273-82.

Plasma diphenylhydantoin levels in Australian adults.

Aust N Z J Med. 1974 Oct;4(5):449-55. doi: 10.1111/j.1445-5994.1974.tb03216.x.

Bioavailability and single-dose pharmacokinetics of intramuscular phenytoin.

Clin Pharmacol Ther. 1975 Oct;18(4):449-56. doi: 10.1002/cpt1975184449.

Comparative study of plasma protein binding of diphenylhydantoin.

Comp Gen Pharmacol. 1973 Dec;4(16):399-404. doi: 10.1016/0010-4035(73)90051-7.

Bioavailability of phenytoin: a comparison between two preparations.

Isr J Med Sci. 1978 Apr;14(4):489-91.

Diphenylhydantoin potency and plasma protein binding.

J Pharmacol Exp Ther. 1975 Oct;195(1):84-6.

Serum concentrations of free diphenylhydantoin and their relationship to clinical intoxication.

Epilepsia. 1973 Jun;14(2):177-84. doi: 10.1111/j.1528-1157.1973.tb03954.x.

引用本文的文献

Impact of generic substitution of anticonvulsants on the treatment of epilepsy.

CNS Drugs. 1997 Aug;8(2):124-33. doi: 10.2165/00023210-199708020-00004.

Stepwise determination of multicompartment disposition and absorption parameters from extravascular concentration-time data. Application to mesoridazine, flurbiprofen, flunarizine, labetalol, and diazepam.

J Pharmacokinet Biopharm. 1991 Aug;19(4):413-55. doi: 10.1007/BF01061665.

Nonlinear assessment of phenytoin bioavailability.

J Pharmacokinet Biopharm. 1976 Aug;4(4):327-36. doi: 10.1007/BF01063122.

Bioavailability of 11 phenytoin products.

J Pharmacokinet Biopharm. 1977 Apr;5(2):133-46. doi: 10.1007/BF01066217.

The bioavailability of phenytoin.

J Neurol. 1977 Oct 7;216(3):155-62. doi: 10.1007/BF00313616.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Bioavailability of diphenylhydantoin.

Clin Pharmacol Ther. 1974 Oct;16(4):727-35. doi: 10.1002/cpt1974164727.

Plasma level studies on different brands of sodium diphenylhydantoin (DPH) and primidone.

Int J Clin Pharmacol Biopharm. 1975 Oct;12(3):309-14.

Bioavailability and dissolution of proprietary and generic formulations of phenytoin.

J Neurol Neurosurg Psychiatry. 1992 Aug;55(8):688-91. doi: 10.1136/jnnp.55.8.688.

[Comparative study of phenytoin availability from pharmaceutical preparations].

Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Neurol Psihiatr Neurochir. 1986 Oct-Dec;31(4):273-82.

Plasma diphenylhydantoin levels in Australian adults.

Aust N Z J Med. 1974 Oct;4(5):449-55. doi: 10.1111/j.1445-5994.1974.tb03216.x.

Bioavailability and single-dose pharmacokinetics of intramuscular phenytoin.

Clin Pharmacol Ther. 1975 Oct;18(4):449-56. doi: 10.1002/cpt1975184449.

Comparative study of plasma protein binding of diphenylhydantoin.

Comp Gen Pharmacol. 1973 Dec;4(16):399-404. doi: 10.1016/0010-4035(73)90051-7.

Bioavailability of phenytoin: a comparison between two preparations.

Isr J Med Sci. 1978 Apr;14(4):489-91.

Diphenylhydantoin potency and plasma protein binding.

J Pharmacol Exp Ther. 1975 Oct;195(1):84-6.

Serum concentrations of free diphenylhydantoin and their relationship to clinical intoxication.

Epilepsia. 1973 Jun;14(2):177-84. doi: 10.1111/j.1528-1157.1973.tb03954.x.

引用本文的文献

Impact of generic substitution of anticonvulsants on the treatment of epilepsy.

CNS Drugs. 1997 Aug;8(2):124-33. doi: 10.2165/00023210-199708020-00004.

J Pharmacokinet Biopharm. 1991 Aug;19(4):413-55. doi: 10.1007/BF01061665.

Nonlinear assessment of phenytoin bioavailability.

J Pharmacokinet Biopharm. 1976 Aug;4(4):327-36. doi: 10.1007/BF01063122.

Bioavailability of 11 phenytoin products.

J Pharmacokinet Biopharm. 1977 Apr;5(2):133-46. doi: 10.1007/BF01066217.

The bioavailability of phenytoin.

J Neurol. 1977 Oct 7;216(3):155-62. doi: 10.1007/BF00313616.